Inter partes review has changed the patent dispute landscape and strategy, and important insights can be gained from the data, explain Corinne Atton of Venable and consultant April Breyer Menon
By Daniel Boehnen -- Last month, the United States government, acting on behalf of its Department of Health and Human Services (HHS), filed suit in Delaware against Gilead Sciences, Inc.
Since the issuance by the United States Supreme Court of its opinion in Alice Corporation Pty Ltd. v. CLS Bank International, 573 U.S. 208, 134 S. Ct.
This is already the fifth post on some amicus curiae briefs filed with the Ninth Circuit in support of the Federal Trade Commission's answer to Qualcomm's appeal--and it won't be the last with at least a couple of submissions from the automotive i
In the January 2019 trial, Qualcomm's #1 problem was that virtually the entire mobile device industry testified against it (apart from a very few companies who, like Qualcomm, refuse to license chipset makers, though a couple of them once lodged t
In its answering brief to Qualcomm's Ninth Circuit antitrust appeal, the FTC says Qualcomm simply "abandoned" its national security argument before the distr
As a branding and marketing professional, I really enjoy seeing how advertising has evolved over the years. Gone are the days of boring, ho-hum advertising campaigns.
As of Saturday morning, 14 (!) amicus curiae briefs supporting the FTC against Qualcomm before the Ninth Circuit have been filed.
This week in Other Barks & Bites: the Federal Circuit issues precedential decisions regarding its authority to remand to the PTAB, patent prosecution history estoppel and expert testimony on motivation to combine for obviousness findings; Chin
Last week, the Federal Trade Commission (FTC) filed its answering brief (prior coverage and commentary: 1,